List of Tables
Table 1. Global Gemcitabine Hydrochloride for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Gemcitabine Hydrochloride for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Gemcitabine Hydrochloride for Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Gemcitabine Hydrochloride for Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Gemcitabine Hydrochloride for Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Gemcitabine Hydrochloride for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Gemcitabine Hydrochloride for Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Gemcitabine Hydrochloride for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Gemcitabine Hydrochloride for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gemcitabine Hydrochloride for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gemcitabine Hydrochloride for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Gemcitabine Hydrochloride for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gemcitabine Hydrochloride for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gemcitabine Hydrochloride for Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gemcitabine Hydrochloride for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Gemcitabine Hydrochloride for Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Gemcitabine Hydrochloride for Injection Sales Market Share by Region (2019-2024)
Table 19. Global Gemcitabine Hydrochloride for Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Gemcitabine Hydrochloride for Injection Sales Market Share by Region (2025-2030)
Table 21. Global Gemcitabine Hydrochloride for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Gemcitabine Hydrochloride for Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Gemcitabine Hydrochloride for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Gemcitabine Hydrochloride for Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Gemcitabine Hydrochloride for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Gemcitabine Hydrochloride for Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Gemcitabine Hydrochloride for Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Gemcitabine Hydrochloride for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Gemcitabine Hydrochloride for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Gemcitabine Hydrochloride for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Gemcitabine Hydrochloride for Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Gemcitabine Hydrochloride for Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Gemcitabine Hydrochloride for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Gemcitabine Hydrochloride for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Gemcitabine Hydrochloride for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Gemcitabine Hydrochloride for Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Gemcitabine Hydrochloride for Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Gemcitabine Hydrochloride for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Gemcitabine Hydrochloride for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gemcitabine Hydrochloride for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Gemcitabine Hydrochloride for Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Gemcitabine Hydrochloride for Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Gemcitabine Hydrochloride for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gemcitabine Hydrochloride for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gemcitabine Hydrochloride for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Gemcitabine Hydrochloride for Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Gemcitabine Hydrochloride for Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Gemcitabine Hydrochloride for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Gemcitabine Hydrochloride for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Gemcitabine Hydrochloride for Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Gemcitabine Hydrochloride for Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Gemcitabine Hydrochloride for Injection Sales Market Share by Type (2019-2024)
Table 53. Global Gemcitabine Hydrochloride for Injection Sales Market Share by Type (2025-2030)
Table 54. Global Gemcitabine Hydrochloride for Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Gemcitabine Hydrochloride for Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Gemcitabine Hydrochloride for Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Gemcitabine Hydrochloride for Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Gemcitabine Hydrochloride for Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Gemcitabine Hydrochloride for Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Gemcitabine Hydrochloride for Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Gemcitabine Hydrochloride for Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Gemcitabine Hydrochloride for Injection Sales Market Share by Application (2019-2024)
Table 63. Global Gemcitabine Hydrochloride for Injection Sales Market Share by Application (2025-2030)
Table 64. Global Gemcitabine Hydrochloride for Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Gemcitabine Hydrochloride for Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Gemcitabine Hydrochloride for Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Gemcitabine Hydrochloride for Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Gemcitabine Hydrochloride for Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Gemcitabine Hydrochloride for Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Sun Pharmaceutical Industries Corporation Information
Table 71. Sun Pharmaceutical Industries Description and Business Overview
Table 72. Sun Pharmaceutical Industries Gemcitabine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sun Pharmaceutical Industries Gemcitabine Hydrochloride for Injection Product
Table 74. Sun Pharmaceutical Industries Recent Developments/Updates
Table 75. Tapi Teva Corporation Information
Table 76. Tapi Teva Description and Business Overview
Table 77. Tapi Teva Gemcitabine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Tapi Teva Gemcitabine Hydrochloride for Injection Product
Table 79. Tapi Teva Recent Developments/Updates
Table 80. Shilpa Medicare Corporation Information
Table 81. Shilpa Medicare Description and Business Overview
Table 82. Shilpa Medicare Gemcitabine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Shilpa Medicare Gemcitabine Hydrochloride for Injection Product
Table 84. Shilpa Medicare Recent Developments/Updates
Table 85. Huachu Industrial Corporation Information
Table 86. Huachu Industrial Description and Business Overview
Table 87. Huachu Industrial Gemcitabine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Huachu Industrial Gemcitabine Hydrochloride for Injection Product
Table 89. Huachu Industrial Recent Developments/Updates
Table 90. Jinkang Pharmaceutical Technology Corporation Information
Table 91. Jinkang Pharmaceutical Technology Description and Business Overview
Table 92. Jinkang Pharmaceutical Technology Gemcitabine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Jinkang Pharmaceutical Technology Gemcitabine Hydrochloride for Injection Product
Table 94. Jinkang Pharmaceutical Technology Recent Developments/Updates
Table 95. Jierui Pharmaceutical Corporation Information
Table 96. Jierui Pharmaceutical Description and Business Overview
Table 97. Jierui Pharmaceutical Gemcitabine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Jierui Pharmaceutical Gemcitabine Hydrochloride for Injection Product
Table 99. Jierui Pharmaceutical Recent Developments/Updates
Table 100. HISUN Corporation Information
Table 101. HISUN Description and Business Overview
Table 102. HISUN Gemcitabine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. HISUN Gemcitabine Hydrochloride for Injection Product
Table 104. HISUN Recent Developments/Updates
Table 105. FUAN PHARMACEUTICAL Corporation Information
Table 106. FUAN PHARMACEUTICAL Description and Business Overview
Table 107. FUAN PHARMACEUTICAL Gemcitabine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. FUAN PHARMACEUTICAL Gemcitabine Hydrochloride for Injection Product
Table 109. FUAN PHARMACEUTICAL Recent Developments/Updates
Table 110. Zhendong Group Corporation Information
Table 111. Zhendong Group Description and Business Overview
Table 112. Zhendong Group Gemcitabine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Zhendong Group Gemcitabine Hydrochloride for Injection Product
Table 114. Zhendong Group Recent Developments/Updates
Table 115. CHIATAI QINGJIANG Corporation Information
Table 116. CHIATAI QINGJIANG Description and Business Overview
Table 117. CHIATAI QINGJIANG Gemcitabine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. CHIATAI QINGJIANG Gemcitabine Hydrochloride for Injection Product
Table 119. CHIATAI QINGJIANG Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Gemcitabine Hydrochloride for Injection Distributors List
Table 123. Gemcitabine Hydrochloride for Injection Customers List
Table 124. Gemcitabine Hydrochloride for Injection Market Trends
Table 125. Gemcitabine Hydrochloride for Injection Market Drivers
Table 126. Gemcitabine Hydrochloride for Injection Market Challenges
Table 127. Gemcitabine Hydrochloride for Injection Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gemcitabine Hydrochloride for Injection
Figure 2. Global Gemcitabine Hydrochloride for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gemcitabine Hydrochloride for Injection Market Share by Type in 2023 & 2030
Figure 4. 200 mg Product Picture
Figure 5. 1000 mg Product Picture
Figure 6. Global Gemcitabine Hydrochloride for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Gemcitabine Hydrochloride for Injection Market Share by Application in 2023 & 2030
Figure 8. Non-Small Cell Lung Cancer
Figure 9. Pancreatic Cancer
Figure 10. Breast Cancer
Figure 11. Others
Figure 12. Global Gemcitabine Hydrochloride for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Gemcitabine Hydrochloride for Injection Market Size (2019-2030) & (US$ Million)
Figure 14. Global Gemcitabine Hydrochloride for Injection Sales (2019-2030) & (K Units)
Figure 15. Global Gemcitabine Hydrochloride for Injection Average Price (US$/Unit) & (2019-2030)
Figure 16. Gemcitabine Hydrochloride for Injection Report Years Considered
Figure 17. Gemcitabine Hydrochloride for Injection Sales Share by Manufacturers in 2023
Figure 18. Global Gemcitabine Hydrochloride for Injection Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Gemcitabine Hydrochloride for Injection Players: Market Share by Revenue in 2023
Figure 20. Gemcitabine Hydrochloride for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Gemcitabine Hydrochloride for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Gemcitabine Hydrochloride for Injection Sales Market Share by Country (2019-2030)
Figure 23. North America Gemcitabine Hydrochloride for Injection Revenue Market Share by Country (2019-2030)
Figure 24. United States Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Gemcitabine Hydrochloride for Injection Sales Market Share by Country (2019-2030)
Figure 27. Europe Gemcitabine Hydrochloride for Injection Revenue Market Share by Country (2019-2030)
Figure 28. Germany Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Gemcitabine Hydrochloride for Injection Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Gemcitabine Hydrochloride for Injection Revenue Market Share by Region (2019-2030)
Figure 35. China Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Gemcitabine Hydrochloride for Injection Sales Market Share by Country (2019-2030)
Figure 43. Latin America Gemcitabine Hydrochloride for Injection Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Gemcitabine Hydrochloride for Injection Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Gemcitabine Hydrochloride for Injection Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Gemcitabine Hydrochloride for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Gemcitabine Hydrochloride for Injection by Type (2019-2030)
Figure 53. Global Revenue Market Share of Gemcitabine Hydrochloride for Injection by Type (2019-2030)
Figure 54. Global Gemcitabine Hydrochloride for Injection Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Gemcitabine Hydrochloride for Injection by Application (2019-2030)
Figure 56. Global Revenue Market Share of Gemcitabine Hydrochloride for Injection by Application (2019-2030)
Figure 57. Global Gemcitabine Hydrochloride for Injection Price (US$/Unit) by Application (2019-2030)
Figure 58. Gemcitabine Hydrochloride for Injection Value Chain
Figure 59. Gemcitabine Hydrochloride for Injection Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
